Products with Vasorelaxation bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3308 | Leachianone G |
| 1. Leachianone G shows inhibitory activities against pancreatic lipase, it may be used as drug candidate to control obesity. 2. (+/-)Leachianone G 1b, bearing 8-prenyl and 2',4'-dihydoxyl groups, exhibits potent vasorelaxant and neuroprotective effects. 3. Leachianone G exhibits significant antioxidant potentials in the ABTS, ONOO(-), and total ROS assays. 4. Leachianone G shows potent antiviral activity (IC(50) = 1.6 microg/ml). | |
| BCN3389 | 8-Hydroxypinoresinol |
| 1. 8-hydroxypinoresinol has antioxidant activity. 2. 8-hydroxypinoresinol and phillygenin significantly reduce the cell injury by 3-morpholinosydnonimine (SIN-1), a ONOO− generator, may be useful for the therapeutic or preventive applications in treating ONOO−-related diseases. | |
| BCN3466 | Isorhyncophylline |
| Isorhyncophylline and rhyncophylline can directly inhibit the contractile responses induced by several agonists in small blood vessels of rat, they also can inhibit the hypertensive effect of angiotensin Ⅱ. | |
| BCN3637 | O-Methylcedrelopsin |
| 1. O-Methylcedrelopsin may have vasorelaxing activity. | |
| BCN3706 | 14-Deoxyandrographolide |
| 1. 14-Deoxyandrographolide desensitizes hepatocytes to TNF-alpha-mediated apoptosis through the release of TNFRSF1A. 2. 14-Deoxyandrographolide has hepatoprotective activity, mediates activation of adenylate cyclase-cAMP signaling leading to up-regulation of cNOS, may provide a promising approach in the prevention of liver diseases during chronic alcoholism. | |
